spacer
home > pmps > summer 2002 > liposomes - successful carrier systems for targeted drug delivery
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Liposomes - Successful Carrier Systems for Targeted Drug Delivery

Liposomes are colloidal, vesicular structures based on (phospho) lipid bilayers. Their characteristics depend on the manufacturing protocol and choice of bilayer components. They can be as small as 20nm and as large as 10Mm in diameter. The liposomes can be unilamellar (meaning only one bilayer surrounds an aqueous core) or multilamellar (several bilayers concentrically oriented around an aqueous core). Moreover, the choice of bilayer components determines the rigidity (or fluidity) and the charge of the bilayer. For example, saturated phospholipids with long acyl chains such as dipalmitoylphosphatidylcholine, form a rigid, rather impermeable bilayer structure, while the unsaturated phosphatidylcholine species from natural sources (egg or soy bean phosphatidylcholine) give much more permeable and less stable bilayers. The introduction of positively or negatively charged lipids provides the liposomes a surface charge. Liposome surfaces can be readily modified. By attaching polyethylene glycol (PEG) units to the bilayer, the circulation time of liposomes in the bloodstream is dramatically increased. Alternatively, homing molecules can be attached to liposome bilayers to make these structures target site specific. Size, lamellarity, bilayer rigidity, charge and bilayer surface modifications all determine the fate of liposomes on the shelf and in vivo. Over the years the behaviour of liposomes has been investigated in much detail (1,2) and algorithms can be used to help the pharmaceutical formulation scientist in selecting the proper liposome type.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Daan Crommelin and Gert Bos of OctoPlus and Gert Storm of the Utrecht Institute for Pharmaceutical Sciences, The Netherlands Professor Daan Crommelin PhD is a Professor at the Department of Pharmaceutics at Utrecht University. He is Scientific Director of the Utrecht Institute for Pharmaceutical Sciences (UIPS) and Adjunct Professor at the Department of Pharmaceutics and Pharmaceutical Chemistry at the University of Utah.
His research focuses on advanced drug delivery and drug targeting strategies. He has published over 240 articles in peer-reviewed journals. Daan is also Chief Scientific Officer of OctoPlus, a Leiden-based company specialising in the development of pharmaceutical product formulations and advanced drug delivery systems..

Gert Bos PhD obtained his masters degree in Chemical Technology in 1993 at the University of Twente. He subsequently earned his PhD in the field of Biomaterial Science from the same university.
He currently combines a postdoctoral research and development function at the faculty of Pharmaceutical Sciences of the Utrecht University (UIPS) and a business development position at OctoPlus in the Netherlands.

Professor Gert Storm PhD obtained is PhD in 1987 on a thesis entitled, Liposomes as delivery system for doxorubicin in cancer therapy. He was appointed as Professor (Drug Targeting Chair) at the University of Utrecht in 2000, and in 1999 as Adjunct Professor at the department of pharmaceutics at the Royal School of Pharmacy, Copenhagen, Denmark. His research interests are in the field of biopharmaceutics and drug targeting.
He published over 180 original articles, reviews and book chapters. He is a member of the editorial (advisory) board of the J. Drug Targeting, J. Liposome Research, S.T.P. Pharma Sciences and Eur. J. Pharm. Sciences, and is Special Features Editor of Pharm. Research. He acts as a Consultant to a number of pharmaceutical companies.

spacer
Gert Bos
spacer
spacer
spacer
Daan Crommelin
spacer
spacer
spacer
Gert Storm
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Entry now open for the PPMA Group Industry Awards 2019

The 2019 PPMA Group Industry Awards will be held at the National Conference Centre (NEC), Birmingham, on the evening of the first day of the PPMA Total Show 2019 Tuesday, 1 October 2019. 
More info >>

White Papers

The Process of Informed Consent (written by ACRP)

CenterWatch

Every investigator and clinical research coordinator (CRC) should recognize the importance of obtaining valid and appropriate informed consent as an important protection of the rights and welfare of human subjects. The purpose of this ACRP guidance document is not to provide a literature review or summarize the recommendations of various working groups. Instead, the Association decided it would be helpful to provide short and focused guidance which describes how to best structure the informed consent process in accordance with best practices.
More info >>

 
Industry Events

FlyPharma Europe

22-23 October 2019, Copenhagen, Denmark

The FlyPharma Conference Europe 2019 is aimed at forward-thinking individuals and businesses that are ready to uncover the potential in their pharma supply chain. The event offers an interactive platform to discuss current and future challenges within pharma and cargo, with topics including market trends, cold chain innovations, latest regulatory demands, security technology, and how to encourage collaboration between supply chain players. There will be plenty of networking opportunities, including a complimentary evening networking event, where delegates can meet and catch up with senior and executive pharma and cargo professionals gaining strong, new industry contacts and building on existing ones.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement